Cholecystokinin (CCK) is an important gastrointestinal and neural polypeptide with a diverse spectrum of biological activity, however, many basic questions remain about the structure and function of CCK receptors. The objective of the proposed research is to isolate a cDNA clone for the CCK receptor and to use this cDNA to analyze the structure, function and tissue specific expression of the CCK receptor. We have recently found that Xenopus laevis oocytes injected with mRNA from AR42J cells, a pancreatic acinar cell line, express functional CCK receptors that can be detected by their ability to increase 45Ca2+ efflux. In the proposed research AR42J cell mRNA will be used to construct cDNA libraries in vectors which allow synthesis of RNA in vitro and the CCK receptor cDNA will be isolated by functional expression in oocytes. Nucleotide sequence data will be obtained from the isolated CCK receptor cDNA and used to determine the primary structure and to predict the secondary structure, hydropathicity, and potential sites for glycosylation, disulfide cross-linking and phosphorylation of the CCK receptor. Expression of the CCK receptor, by injection of transcribed RNA into Xenopus oocytes and by subcloning the cDNA into eukaryotic expression vectors and transfecting a variety of cell lines, will provide valuable information about CCK receptor function. Exogenously expressed CCK receptors will be tested for their abilities to bind CCK, internalize CCK, increase phosphoinositide turnover, increase intracellular Ca2+ release, and interact with guanine nucleotide binding proteins. Functional domains of the CCK receptor will then be elucidated both by perturbation (e.g. site-directed mutagenesis) leading to loss of function, and by construction of chimeric receptors leading to acquisition of functions. The cloned CCK receptor cDNA will also be used to determine the tissue specificity of CCK receptor expression. mRNA prepared from a variety of tissues will be analyzed by Northern blot hybridization. Differences between the cloned CCK receptor cDNA and homologous mRNAs found in other tissue will be further elucidated using RNase protection and primer extension methods.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK041350-04
Application #
3242071
Study Section
Physiological Chemistry Study Section (PC)
Project Start
1989-05-01
Project End
1994-04-30
Budget Start
1992-05-01
Budget End
1993-04-30
Support Year
4
Fiscal Year
1992
Total Cost
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Type
Schools of Medicine
DUNS #
791277940
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Yang, J; Williams, J A; Yule, D I et al. (1995) Mutation of carboxyl-terminal threonine residues in human m3 muscarinic acetylcholine receptor modulates the extent of sequestration and desensitization. Mol Pharmacol 48:477-85
Tseng, M J; Coon, S; Stuenkel, E et al. (1995) Influence of second and third cytoplasmic loops on binding, internalization, and coupling of chimeric bombesin/m3 muscarinic receptors. J Biol Chem 270:17884-91
Yang, J; Logsdon, C D; Johansen, T E et al. (1993) Human m3 muscarinic acetylcholine receptor carboxyl-terminal threonine resides are required for agonist-induced receptor down-regulation. Mol Pharmacol 44:1158-64
Yule, D I; Tseng, M J; Williams, J A et al. (1993) A cloned CCK-A receptor transduces multiple signals in response to full and partial agonists. Am J Physiol 265:G999-1004
Scheuner, D; Logsdon, C D; Holz, R W (1992) Bovine chromaffin granule membranes undergo Ca(2+)-regulated exocytosis in frog oocytes. J Cell Biol 116:359-65
Gantz, I; Schaffer, M; DelValle, J et al. (1991) Molecular cloning of a gene encoding the histamine H2 receptor. Proc Natl Acad Sci U S A 88:429-33